John Collinge

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi Molecular pathology of human prion disease
    Jonathan D F Wadsworth
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
    Acta Neuropathol 121:69-77. 2011
  2. ncbi A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea
    John Collinge
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3725-39. 2008
  3. ncbi Review. Lessons of kuru research: background to recent studies with some personal reflections
    John Collinge
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3689-96. 2008
  4. ncbi Reminiscences and reflections on kuru, personal and scientific
    John Collinge
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Philos Trans R Soc Lond B Biol Sci 363:3613. 2008
  5. ncbi A general model of prion strains and their pathogenicity
    John Collinge
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London WC1N 3BG, UK
    Science 318:930-6. 2007
  6. ncbi Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
    John Collinge
    National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospital National Health Service Foundation Trust, Queen Square, London WC1N 3BG, UK
    Lancet Neurol 8:334-44. 2009
  7. ncbi Kuru in the 21st century--an acquired human prion disease with very long incubation periods
    John Collinge
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, UK
    Lancet 367:2068-74. 2006
  8. ncbi Molecular neurology of prion disease
    J Collinge
    MRC Prion Unit and National Prion Clinic, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Neurol Neurosurg Psychiatry 76:906-19. 2005
  9. ncbi Human prion protein with valine 129 prevents expression of variant CJD phenotype
    Jonathan D F Wadsworth
    Medical Research Council MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Science 306:1793-6. 2004
  10. ncbi Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study
    Simon Mead
    Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London, UK
    Lancet Neurol 8:57-66. 2009

Detail Information

Publications133 found, 100 shown here

  1. ncbi Molecular pathology of human prion disease
    Jonathan D F Wadsworth
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
    Acta Neuropathol 121:69-77. 2011
    ..Understanding these relationships will have direct translation to protecting public health...
  2. ncbi A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea
    John Collinge
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3725-39. 2008
    ..Importantly, no evidence for lymphoreticular colonization with prions, seen uniformly in vCJD, was observed in a patient with kuru at tonsil biopsy...
  3. ncbi Review. Lessons of kuru research: background to recent studies with some personal reflections
    John Collinge
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3689-96. 2008
    ..Although now essentially over, the kuru epidemic continues to provide important lessons...
  4. ncbi Reminiscences and reflections on kuru, personal and scientific
    John Collinge
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Philos Trans R Soc Lond B Biol Sci 363:3613. 2008
  5. ncbi A general model of prion strains and their pathogenicity
    John Collinge
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London WC1N 3BG, UK
    Science 318:930-6. 2007
    ..Recent advances suggest that prions themselves are not directly neurotoxic, but rather their propagation involves production of toxic species, which may be uncoupled from infectivity...
  6. ncbi Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
    John Collinge
    National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospital National Health Service Foundation Trust, Queen Square, London WC1N 3BG, UK
    Lancet Neurol 8:334-44. 2009
    ....
  7. ncbi Kuru in the 21st century--an acquired human prion disease with very long incubation periods
    John Collinge
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, UK
    Lancet 367:2068-74. 2006
    ..We investigated possible incubation periods, pathogenesis, and genetic susceptibility factors in kuru patients in Papua New Guinea...
  8. ncbi Molecular neurology of prion disease
    J Collinge
    MRC Prion Unit and National Prion Clinic, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Neurol Neurosurg Psychiatry 76:906-19. 2005
    ....
  9. ncbi Human prion protein with valine 129 prevents expression of variant CJD phenotype
    Jonathan D F Wadsworth
    Medical Research Council MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Science 306:1793-6. 2004
    ..Thus, primary and secondary human infection with BSE-derived prions may result in sporadic CJD-like or novel phenotypes in addition to vCJD, depending on the genotype of the prion source and the recipient...
  10. ncbi Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study
    Simon Mead
    Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London, UK
    Lancet Neurol 8:57-66. 2009
    ....
  11. ncbi The H187R mutation of the human prion protein induces conversion of recombinant prion protein to the PrP(Sc)-like form
    Laszlo L P Hosszu
    MRC Prion Unit, UCL Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, UK
    Biochemistry 49:8729-38. 2010
    ..This mutation is distinct from all those associated with GSS, which have much more subtle physical consequences. The degree of instability might be the cause of the unusually early onset of mental disturbance in affected individuals...
  12. ncbi Conformational properties of beta-PrP
    Laszlo L P Hosszu
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, UK
    J Biol Chem 284:21981-90. 2009
    ..This precursor state is almost as compact as the folded PrPC structure and, as it assembles, only residues 126-227 are immobilized within the oligomeric structure, leaving the remainder in a mobile, random-coil state...
  13. ncbi Beta-PrP form of human prion protein stimulates production of monoclonal antibodies to epitope 91-110 that recognise native PrPSc
    Azadeh Khalili-Shirazi
    MRC Prion Unit, Department of Neurodegenerative Diseases, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Biochim Biophys Acta 1774:1438-50. 2007
    ..These results demonstrate strain-dependent variations in chain conformation and packing within the 91-110 region of PrP(Sc)...
  14. ncbi Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity
    Simon Mead
    MRC Prion Unit, Department of Neurodegenerative Diseases, Institute of Neurology, King's College Hospital, London, UK
    Brain 129:2297-317. 2006
    ....
  15. ncbi Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations
    Andrew F Hill
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Brain 129:676-85. 2006
    ..These data extend the spectrum of recognized PrP(Sc) types seen in human prion diseases and provide further insight into the generation of diverse clinicopathological phenotypes associated with inherited prion disease...
  16. ncbi Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein
    Jonathan D F Wadsworth
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery Queen Square, London, UK
    Brain 129:1557-69. 2006
    ..Such differential propagation of disease-related isoforms of wild-type PrP and PrP 102L provides a molecular mechanism for generation of the multiple clinicopathological phenotypes seen in inherited prion disease...
  17. ncbi PrP glycoforms are associated in a strain-specific ratio in native PrPSc
    Azadeh Khalili-Shirazi
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    J Gen Virol 86:2635-44. 2005
    ..These studies are consistent with the view that the proportion of each glycoform incorporated into PrPSc is probably controlled in a strain-specific manner and that each PrPSc particle contains a mixture of glycoforms...
  18. ncbi Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice
    Jonathan D F Wadsworth
    Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom
    Proc Natl Acad Sci U S A 105:3885-90. 2008
    ..These findings are consistent with the hypothesis that kuru originated from chance consumption of an individual with sporadic CJD...
  19. ncbi Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics
    Simon Mead
    Medical Research Council Prion Unit, and Department of Neurodegenerative Disease, Institute of Neurology, University College, Queen Square, London WC1N 3BG, UK
    Science 300:640-3. 2003
    ..Worldwide PRNP haplotype diversity and coding allele frequencies suggest that strong balancing selection at this locus occurred during the evolution of modern humans...
  20. ncbi Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice
    Emmanuel A Asante
    Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, United Kingdom
    Proc Natl Acad Sci U S A 103:10759-64. 2006
    ..These data argue that human PRNP 129 heterozygotes will be more susceptible to infection with vCJD prions than to cattle BSE prions and may present with a neuropathological phenotype distinct from vCJD...
  21. ncbi Molecular and clinical classification of human prion disease
    Jonathan D F Wadsworth
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College, London, UK
    Br Med Bull 66:241-54. 2003
    ..A molecular classification of human prion diseases seems achievable through characterisation of structural differences of the infectious agent itself...
  22. ncbi Genetic susceptibility, evolution and the kuru epidemic
    Simon Mead
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3741-6. 2008
    ..Kuru may have imposed the strongest episode of recent human balancing selection, which may not have been an isolated episode in human history...
  23. ncbi Codon 129 polymorphism of the human prion protein influences the kinetics of amyloid formation
    Patrick A Lewis
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    J Gen Virol 87:2443-9. 2006
    ..However, in a partially denatured conformation, the polymorphic variation has a profound influence on the ability of the protein to form amyloid fibrils spontaneously...
  24. ncbi HECTD2 is associated with susceptibility to mouse and human prion disease
    Sarah E Lloyd
    MRC Prion Unit, University College London Institute of Neurology, London, United Kingdom
    PLoS Genet 5:e1000383. 2009
    ..Characterisation of such genes is key to understanding human risk and the molecular basis of incubation periods...
  25. ncbi Identification and characterization of a novel mouse prion gene allele
    Sarah E Lloyd
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College, London, WC1N 3BG, UK
    Mamm Genome 15:383-9. 2004
    ..We conclude that the new allele, Prnp(c), modulates incubation time but not neuropathology and that the previous classification of mice into two distinct groups based on incubation time and Prnp genotype should now be revised...
  26. ncbi PRNP allelic series from 19 years of prion protein gene sequencing at the MRC Prion Unit
    Jon A Beck
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
    Hum Mutat 31:E1551-63. 2010
    ..New genotype-phenotype correlations and population frequencies presented will help the diagnosis and genetic counselling of those with suspected inherited prion disease...
  27. ncbi Parietal lobe deficits in frontotemporal lobar degeneration caused by a mutation in the progranulin gene
    Jonathan D Rohrer
    Dementia Research Centre, Institute of Neurology, University College London, London, England
    Arch Neurol 65:506-13. 2008
    ..To describe the clinical, neuropsychologic, and radiologic features of a family with a C31LfsX35 mutation in the progranulin gene CCDS11483.1)...
  28. ncbi Disease-associated prion protein oligomers inhibit the 26S proteasome
    Mark Kristiansen
    MRC Prion Unit, Institute of Neurology, University College London, Queen Square, London, UK
    Mol Cell 26:175-88. 2007
    ..Together, these data suggest a mechanism for intracellular neurotoxicity mediated by oligomers of misfolded prion protein...
  29. ncbi Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors
    Diego N Kaski
    National Prion Clinic, National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
    Brain 134:1829-38. 2011
    ..These findings may provide a precedent for understanding apparently sporadic neurodegenerative diseases caused by rare high-risk mutations...
  30. ncbi Mapping the progression of progranulin-associated frontotemporal lobar degeneration
    Jonathan D Rohrer
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Nat Clin Pract Neurol 4:455-60. 2008
    ..The patient was initially asymptomatic but developed progressive behavioral and cognitive decline characterized by apathy, impaired emotion recognition, mixed aphasia and parietal lobe dysfunction...
  31. ncbi Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease
    Melanie D White
    Department of Neurodegenerative Disease, Medical Research Council, Prion Unit Institute of Neurology, University College London, London, United Kingdom
    Proc Natl Acad Sci U S A 105:10238-43. 2008
    ....
  32. ncbi Review. The origin of the prion agent of kuru: molecular and biological strain typing
    Jonathan D F Wadsworth
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3747-53. 2008
    ..Here, we review these findings and discuss how peripheral routes of infection and other factors may be critical modifiers of the kuru phenotype...
  33. ncbi A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series
    Jonathan Beck
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Brain 131:706-20. 2008
    ..Finally, we confirmed a modifying effect of APOE-E4 genotype on clinical phenotype with a later onset in the GRN carriers suggesting that this gene has distinct phenotypic effects in different neurodegenerative diseases...
  34. ncbi Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis
    Mark Kristiansen
    Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom
    J Biol Chem 280:38851-61. 2005
    ..This, in turn, triggers caspase-dependent apoptosis and further implicates proteasome dysfunction in the pathogenesis of prion diseases...
  35. ncbi Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman
    Simon Mead
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Arch Neurol 64:1780-4. 2007
    ..Modeling studies in transgenic mice suggest that other PRNP genotypes will also be susceptible to infection with bovine spongiform encephalopathy prions but may develop distinctive phenotypes...
  36. ncbi Definable equilibrium states in the folding of human prion protein
    Laszlo L P Hosszu
    MRC Prion Unit and National Prion Clinic, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Biochemistry 44:16649-57. 2005
    ..Residual structure within this state is extensive and encompasses the majority of the secondary structure elements found in the native state of the protein...
  37. ncbi Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins
    Emmanuel A Asante
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Gen Virol 90:546-58. 2009
    ..These data indicate that P102L or E200K mutations of human PrP have differing effects on prion propagation that depend upon prion strain type and can be significantly influenced by mismatch at the polymorphic residue 129...
  38. ncbi Recombinant prion protein does not possess SOD-1 activity
    Samantha Jones
    MRC Prion Unit, Department of Neurodegenerative Diseases, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Biochem J 392:309-12. 2005
    ..Thus if PrP has any role in oxidative stress, it must be indirect as a regulator of protective cellular responses...
  39. ncbi Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay
    Julie Ann Edgeworth
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
    Lancet 377:487-93. 2011
    ..We aimed to establish the sensitivity and specificity of a blood-based assay for detection of vCJD prion infection...
  40. ncbi Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study
    Jonathan D F Wadsworth
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Pathol 223:511-8. 2011
    ..In this context, the Hilton et al study should continue to inform risk assessment pending the outcome of larger-scale studies on discarded surgical tissues and autopsy samples...
  41. ncbi Prion propagation and toxicity in vivo occur in two distinct mechanistic phases
    Malin K Sandberg
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK
    Nature 470:540-2. 2011
    ..Production of neurotoxic species is triggered when prion propagation saturates, leading to a switch from autocatalytic production of infectivity (phase 1) to a toxic (phase 2) pathway...
  42. ncbi Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid
    Laura D'Castro
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, United Kingdom
    PLoS ONE 5:e15679. 2010
    ..This procedure now allows characterization of proteinase K-sensitive prions and investigation of their clinical relevance in human and animal prion disease without being confounded by contaminating PrP(C)...
  43. ncbi Spontaneous generation of mammalian prions
    Julie A Edgeworth
    Medical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, London WC1N 3BG, United Kingdom
    Proc Natl Acad Sci U S A 107:14402-6. 2010
    ..Alternatively, if prions were naturally present in the brain at levels not detectable by conventional methods, metal surfaces might concentrate them to the extent that they become quantifiable by the scrapie cell assay...
  44. ncbi Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice
    Giovanna R Mallucci
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom
    Neuron 53:325-35. 2007
    ..These data suggest that early intervention in human prion disease may lead to recovery of cognitive and behavioral symptoms...
  45. ncbi Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein
    Adam Frosh
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Lancet 364:1260-2. 2004
    ..Nevertheless, our findings establish a protocol for prevalence screening on a national scale...
  46. ncbi Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin
    Sabrina Cronier
    MRC Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N3BG, UK
    Biochem J 416:297-305. 2008
    ..Detection of PK-sensitive isoforms of disease-related PrP using thermolysin should be useful for improving diagnostic sensitivity in human prion diseases...
  47. ncbi Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis
    Ruth Chia
    Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom
    PLoS ONE 5:e10627. 2010
    ..Although different mutations lead to varying tendencies of SOD1 to aggregate, we suggest abnormal proteins share a common misfolding pathway that leads to the formation of amyloid fibrils...
  48. ncbi Molecular diagnosis of human prion disease
    Jonathan D F Wadsworth
    MRC Prion Unit, University College London Institute of Neurology, London, UK
    Methods Mol Biol 459:197-227. 2008
    ....
  49. ncbi The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC
    Laszlo L P Hosszu
    Medical Research Council Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, United Kingdom
    J Biol Chem 279:28515-21. 2004
    ..We infer that the M/V effect is mediated through the conformation or stability of disease-related PrP (PrP(Sc)) or intermediates or on the kinetics of their formation...
  50. ncbi Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice
    Sarah E Lloyd
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College, London WC1N 3BG, UK
    J Gen Virol 85:2471-8. 2004
    ..It is possible that multiple disease phenotypes may also be possible in BSE prion infection in humans and other animals...
  51. ncbi Subclinical prion infection in humans and animals
    Andrew F Hill
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, London, UK
    Br Med Bull 66:161-70. 2003
    ..Subclinical as well as preclinical/clinical prion disease may be relevant when analysing the risk to public health of potential sources of prion exposure...
  52. ncbi A Copine family member, Cpne8, is a candidate quantitative trait gene for prion disease incubation time in mouse
    Sarah E Lloyd
    Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK
    Neurogenetics 11:185-91. 2010
    ..We also show that Cpne8 mRNA is upregulated at the terminal stage of disease, supporting a role in prion disease. Applying these techniques to other loci will facilitate the identification of key pathways in prion disease pathogenesis...
  53. ncbi HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q
    Sarah E Lloyd
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK
    BMC Med Genet 10:90. 2009
    ..In this study we test whether the HECTD2 susceptibility allele seen in prion disease is also implicated in LOAD...
  54. ncbi Folding kinetics of the human prion protein probed by temperature jump
    Tanya Hart
    Medical Research Council Prion Unit, Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom
    Proc Natl Acad Sci U S A 106:5651-6. 2009
    ..It is notable that in inherited forms of human prion disease, where point mutations produce a lethal dominant condition, 20 of the 33 amino acid replacements occur in the helix-2/3 sequence...
  55. ncbi An enzyme-detergent method for effective prion decontamination of surgical steel
    Graham S Jackson
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    J Gen Virol 86:869-78. 2005
    ..The prion-degrading reagents identified in this study are readily available, inexpensive, non-corrosive to instruments, non-hazardous to staff and compatible with current equipment and procedures used in hospital sterilization units...
  56. ncbi Tau, prions and A?: the triad of neurodegeneration
    Lilla Reiniger
    Division of Neuropathology, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, WC1N 3BG, London, UK
    Acta Neuropathol 121:5-20. 2011
    ..This includes the novel finding that tau phosphorylation consistently occurs in sporadic CJD, in the absence of amyloid plaques...
  57. ncbi Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse
    Marie O'Shea
    Medical Research Council Prion Unit and Department of Neurodegenerative Diseases, Institute of Neurology, University College, London WC1N 3BG, United Kingdom
    Genetics 180:559-66. 2008
    ..In these models loss of Mcp1 did not show an increase in incubation time suggesting that the effects of Mcp1 may be specific to the ME7 prion strain and that Mcp1 does not contribute to the QTL described on Mmu11...
  58. ncbi Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report
    Stephen J Wroe
    National Prion Clinic, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Lancet 368:2061-7. 2006
    ..Tonsil biopsy will allow early and pre-symptomatic diagnosis in other iatrogenically exposed individuals at high risk, as in those with primary infection with bovine spongiform encephalopathy prions...
  59. ncbi Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases
    Durrenajaf Siddique
    Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Brain 133:3058-68. 2010
    ..The magnetic resonance imaging measurement of magnetization transfer ratios may be an in vivo surrogate for spongiform change and has potential utility as a therapeutic biomarker in human prion disease...
  60. ncbi Inhibition of proteinase K activity by copper(II) ions
    Lisa A Stone
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, U K
    Biochemistry 46:245-52. 2007
    ..Under these conditions, the apparent resistance of PrPC to proteolysis by PK appears to be directly attributable to the inhibition of PK activity by copper(II) ions...
  61. ncbi Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity
    Patrick A Lewis
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Biochem J 395:443-8. 2006
    ..These results show that the GPI anchor has little or no role in either the propagation of PrP(Sc) or on prion infectivity...
  62. ncbi Pathogenic human prion protein rescues PrP null phenotype in transgenic mice
    Emmanuel A Asante
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    Neurosci Lett 360:33-6. 2004
    ..Using the AHP as a marker for PrP function, we conclude that this pathogenic PrP mutation, does not significantly affect the normal neuronal function of PrP...
  63. ncbi Protein conformation significantly influences immune responses to prion protein
    Azadeh Khalili-Shirazi
    Department of Neurodegenerative Disease, Institute of Neurology, University College London, London, United Kingdom
    J Immunol 174:3256-63. 2005
    ..These differences may be exploitable diagnostically and therapeutically for prion diseases, such as variant Creutzfeldt-Jakob disease...
  64. ncbi Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis
    Giovanna Mallucci
    Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1, UK
    Science 302:871-4. 2003
    ..Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity...
  65. ncbi Identification of genetic loci affecting mouse-adapted bovine spongiform encephalopathy incubation time in mice
    Sarah E Lloyd
    MRC Prion Unit, Department of Neurodegenerative Diseases, Institute of Neurology, University College, London, W21N 3BG, UK
    Neurogenetics 4:77-81. 2002
    ..This provides hope that it may be possible to identify human quantitative trait loci for prion incubation time using mouse models that may allow identification of at-risk individuals and the discovery of novel therapeutic targets...
  66. ncbi Shadoo (Sprn) and prion disease incubation time in mice
    Sarah E Lloyd
    MRC Prion Unit and Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK
    Mamm Genome 20:367-74. 2009
    ..We therefore conclude that Sprn does not play a major role in prion disease incubation time in these strains of mice...
  67. ncbi Mortuary rites of the South Fore and kuru
    Jerome T Whitfield
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3721-4. 2008
    ..The exclusion of alternative routes of transmission is of importance owing to the dietary exposure of the UK and other populations to bovine spongiform encephalopathy prions...
  68. ncbi BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein
    Emmanuel A Asante
    MRC Prion Unit, Institute of Neurology, University College, Queen Square, London WC1N 3BG, UK
    EMBO J 21:6358-66. 2002
    ..These data suggest that more than one BSE-derived prion strain might infect humans; it is therefore possible that some patients with a phenotype consistent with sporadic CJD may have a disease arising from BSE exposure...
  69. ncbi Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein
    Malin K Sandberg
    MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Gen Virol 91:2651-7. 2010
    ..However, it is possible that CWD may be caused by multiple prion strains. Further studies will be required to evaluate the transmission properties of distinct cervid prion strains as they are characterized...
  70. ncbi A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes
    Jonathan D Rohrer
    Dementia Research Centre, Institute of Neurology, Queen Square, London, WC1N 3BG, UK
    J Neurol 258:1494-6. 2011
    ..Together these cases suggest a potential for the same VCP mutation to produce distinct patterns of brain damage, underlining the clinical heterogeneity of VCP-associated disease...
  71. ncbi Species-barrier-independent prion replication in apparently resistant species
    Andrew F Hill
    Department of Neurodegenerative Diseases, Institute of Neurology, University College London, UK
    APMIS 110:44-53. 2002
    ..Here the issue of subclinical prion diseases is reviewed and implications are discussed...
  72. ncbi Neuroimaging findings in human prion disease
    R G MacFarlane
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, London, UK
    J Neurol Neurosurg Psychiatry 78:664-70. 2007
    ..This paper reviews the current knowledge of imaging appearances in human prion disease...
  73. ncbi A novel presenilin 1 deletion (p.L166del) associated with early onset familial Alzheimer's disease
    W D Knight
    Dementia Research Centre, Institute of Neurology, University College London, London, UK
    Eur J Neurol 14:829-31. 2007
    ..They are, however, consistent with the reported clinical phenotype in the majority of PSEN1 exon 6 mutations so far reported...
  74. ncbi Review: contribution of transgenic models to understanding human prion disease
    J D F Wadsworth
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, London, UK
    Neuropathol Appl Neurobiol 36:576-97. 2010
    ....
  75. ncbi Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy
    A D Waldman
    Dementia Research Group, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, WC1 3BG, UK
    Neuroradiology 48:428-33. 2006
    ....
  76. ncbi The cellular prion protein is preferentially expressed by CD4+ CD25+ Foxp3+ regulatory T cells
    Jeremy D Isaacs
    Department of Infectious Diseases and Immunity, Imperial College, Hammersmith Hospital, London, UK
    Immunology 125:313-9. 2008
    ..Nevertheless, the preferential expression of surface PrP(C) by regulatory T cells raises the possibility that therapeutic ligation of PrP(C) might alter immune regulation...
  77. ncbi Prion strains and species barriers
    Andrew F Hill
    MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, London, UK
    Contrib Microbiol 11:33-49. 2004
  78. ncbi Introduction
    John Collinge
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Philos Trans R Soc Lond B Biol Sci 363:3607-12. 2008
  79. ncbi Elongated oligomers assemble into mammalian PrP amyloid fibrils
    M Howard Tattum
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK
    J Mol Biol 357:975-85. 2006
    ....
  80. ncbi Age of onset and death in inherited prion disease are heritable
    T E F Webb
    MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Am J Med Genet B Neuropsychiatr Genet 150:496-501. 2009
    ....
  81. ncbi Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series
    T E F Webb
    Department of Neurodegenerative Disease and MRC Prion Unit, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Brain 131:2632-46. 2008
    ..These data allow an appreciation of the range of clinical phenotype, modern imaging and molecular investigation and should inform genetic counselling of at-risk individuals, with the identification of two genetic modifiers...
  82. ncbi Human prion diseases and bovine spongiform encephalopathy (BSE)
    J Collinge
    Prion Disease Group, Neurogenetics Unit, Imperial College School of Medicine at St Mary s, London, UK
    Hum Mol Genet 6:1699-705. 1997
    ..Such molecular analysis of prion strains suggests that new variant Creutzfeldt-Jakob disease is caused by BSE exposure. The novel biology of prion propagation may not be unique to these rare degenerative brain diseases...
  83. ncbi Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene
    R J Harvey
    Dementia Research Group, The National Hospital for Neurology and Neurosurgery and Imperial College School of Medicine at St Mary s, London, UK
    J Neurol Neurosurg Psychiatry 64:44-9. 1998
    ....
  84. ncbi Early onset familial Alzheimer's disease: Mutation frequency in 31 families
    J C Janssen
    Dementia Research Group, Department of Clinical Neurology, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, UK
    Neurology 60:235-9. 2003
    ..There may be a further genetic factor involved in the etiology of autosomal dominant early onset AD...
  85. ncbi The neuropsychology of variant CJD: a comparative study with inherited and sporadic forms of prion disease
    R J Cordery
    Dementia Research Group, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    J Neurol Neurosurg Psychiatry 76:330-6. 2005
    ..The results also suggest that nominal function may be preserved in some cases with inherited prion disease...
  86. ncbi Update on Creutzfeldt-Jakob disease
    Giovanna Mallucci
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK
    Curr Opin Neurol 17:641-7. 2004
    ..Prevention of the formation of such a species rather than PrP(Sc) accumulation itself is a clear target for prion therapeutics...
  87. ncbi Prion disease incubation time is not affected in mice heterozygous for a dynein mutation
    Majid Hafezparast
    Department of Neurodegenerative Disease, Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Biochem Biophys Res Commun 326:18-22. 2005
    ..Our data indicate that the dynein mutation in the heterozygous state does not affect prion disease incubation time or its neuropathology in Loa mice...
  88. ncbi Prion diseases
    Edward McKintosh
    Department of Neurodegenerative Disease/MRC Prion Unit, Institute of Neurology, University College London, London, United Kingdom
    J Neurovirol 9:183-93. 2003
    ..This article reviews the history and epidemiology of these diseases, and then focuses on important areas of current research in human prion disorders...
  89. ncbi A systematic review of prion therapeutics in experimental models
    Clare R Trevitt
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London, UK
    Brain 129:2241-65. 2006
    ....
  90. ncbi Preventing prion pathogenicity by targeting the cellular prion protein
    Andrew J Nicoll
    Department of Neurodegenerative Disease, MRC Prion Unit, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
    Infect Disord Drug Targets 9:48-57. 2009
    ..Recent work has provided proof of principle that compounds which bind selectively to the cellular prion protein could act as therapeutics for prion diseases...
  91. ncbi The molecular pathology of CJD: old and new variants
    G S Jackson
    MRC Prion Unit, Department of Neurogenetics, Imperial College School of Medicine at St Mary s, Norfolk Place, Paddington, London W2 1NY, UK
    Mol Pathol 54:393-9. 2001
    ..Concomitantly, advances in the fundamental biology of prion disease have done much to reinforce the protein only hypothesis of prion replication...
  92. ncbi Prion disease--the propagation of infectious protein topologies
    G S Jackson
    MRC Prion Unit, Department of Neurogenetics, Imperial College School of Medicine at St Mary s, W2 1PG, London, UK
    Microbes Infect 2:1445-9. 2000
    ..Concomitantly, advances in the analysis of the abnormal isoform, PrP(Sc), have expanded our knowledge on the molecular basis of prion strains and have done much to reinforce the protein-only hypothesis of prion replication...
  93. ncbi Phenotypic variability in the brains of a family with a prion disease characterized by a 144-base pair insertion in the prion protein gene
    A King
    Department of Neuropathology, Institute of Psychiatry, Kings College London, London, UK
    Neuropathol Appl Neurobiol 29:98-105. 2003
    ..They also reveal that the relationship between PrP deposition and cerebral or cerebellar damage might be complex...
  94. ncbi A presenilin 1 R278I mutation presenting with language impairment
    A K Godbolt
    Dementia Research Centre, Department of Neurodegenerative Disease, Institute of Neurology, London, UK
    Neurology 63:1702-4. 2004
    ..Screening for PSEN1 mutations may be appropriate in cases of familial dementia even where the clinical phenotype is not typical of AD...
  95. ncbi Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
    J Collinge
    Neurogenetics Unit, Department of Biochemistry and Molecular Genetics, Imperial College School of Medicine at St Mary s, London, UK
    Nature 383:685-90. 1996
    ..Strain characteristics revealed here suggest that the prion protein may itself encode disease phenotype...
  96. ncbi Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129
    S Mead
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London, UK
    Neurology 69:730-8. 2007
    ..An individual inherited prion disease offers an opportunity to study the determinants of this clinicopathologic heterogeneity among individuals with the same causal mutation...
  97. ncbi The human prion protein residue 129 polymorphism lies within a cluster of epitopes for T cell recognition
    Jeremy D Isaacs
    Human Disease Immunogenetics Group, Department of Infectious Diseases and Immunity, Imperial College, Hammersmith Hospital, London, UK
    J Neuropathol Exp Neurol 65:1059-68. 2006
    ....
  98. ncbi Two-octapeptide repeat deletion of prion protein associated with rapidly progressive dementia
    J A Beck
    MRC Prion Unit, Department of Neurogenetics, Imperial College School of Medicine at St. Mary's, London, UK
    Neurology 57:354-6. 2001
    ..This mutation was absent from more than 3,000 individuals and may be causally related to prion disease and represent a novel disease mechanism...
  99. ncbi Mutations and polymorphisms in the prion protein gene
    M S Palmer
    Department of Biochemistry and Molecular Genetics, St Mary s Hospital Medical School, Norfolk Place, London, UK
    Hum Mutat 2:168-73. 1993
    ..The identification of mutations in this gene has lead to a broadening of the spectrum of clinical phenotypes that can be classified as prion diseases and have provided an important tool in the diagnosis of familial dementias...
  100. ncbi Prion infectivity in variant Creutzfeldt-Jakob disease rectum
    J D F Wadsworth
    MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
    Gut 56:90-4. 2007
    ..To date PrP(Sc):prion infectivity ratios have not been determined in vCJD, and it is unknown whether vCJD prions are similar to experimental rodent prions, where PrP(Sc) concentration typically reflects infectious prion titre...
  101. ncbi Variant Creutzfeldt-Jakob disease
    J Collinge
    Department of Neurogenetics, Imperial College School of Medicine at St Mary s, London, UK
    Lancet 354:317-23. 1999
    ..The theoretical possibility that BSE prions might have transferred to other species and continue to present a risk to human health cannot be excluded at present...